- Home
- BCRX vs BFLY Comparison
BCRX vs BFLY Comparison
Compare BCRX & BFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | BFLY |
|---|---|---|
| Founded | 1986 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BCRX | BFLY |
|---|---|---|
| Price | $7.63 | $6.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $20.55 | $11.17 |
| AVG Volume (30 Days) | ★ 5.1M | 4.8M |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | 8.82 |
| EPS | N/A | ★ N/A |
| Revenue | $25,186,000.00 | ★ $97,610,000.00 |
| Revenue This Year | N/A | $27.72 |
| Revenue Next Year | $3.71 | $21.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.96 |
| 52 Week Low | $6.23 | $1.90 |
| 52 Week High | $11.22 | $10.21 |
Technical Indicators
Market Signals| Indicator | BCRX | BFLY |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 43.08 |
| Support Level | $7.95 | $6.35 |
| Resistance Level | $9.22 | $9.86 |
| Average True Range (ATR) | 0.33 | 0.50 |
| MACD | 0.08 | -0.07 |
| Stochastic Oscillator | 53.73 | 37.97 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About BFLY Butterfly Network Inc.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.